J A Kemp is one of Europe’s leading filers of patent applications relating to cell and gene therapies. In this webinar, partners Lucy Barnes and Lucy Williams draw on their extensive experience in this field to explore strategies for securing effective patent protection for cell and gene therapies.
They consider how patent strategy can support investment and licensing, strengthen competitive position, and help build commercially valuable protection around both therapeutic products and platform technologies.
Topics include:
- What value can patents provide? How can patent protection support the commercial development of cell and gene therapies?
- What can be patented? Which claim categories are most useful, what scope of protection may be available, and to what extent can platform technologies be protected?